🇺🇸 FDA
Patent

US 9856453

Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject

granted A61KA61K2039/585A61K2239/56

Quick answer

US patent 9856453 (Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/585, A61K2239/56, A61K35/12, A61K35/17